Prognostic Value of the Systemic Inflammation Response Index in Patients with Adenocarcinoma of the Oesophagogastric Junction: A Propensity Score-Matched Analysis
Table 1
Baseline characteristics for patients with versus before and after propensity matching.
Clinical parameter
Unmatched (complete) dataset
Matched (1 : 1) dataset
(116)
(186)
2
SD
(104)
(104)
2
SD
Sex
14.60
<0.001
0.12
0.734
Male
81
163
0.08
81
83
0.09
Female
35
23
0.08
23
21
0.09
Age
1.89
0.169
0.02
0.887
≤60
51
67
42
41
>60
65
119
62
63
Grade
8.33
0.016
2.06
0.356
Well
11
4
9
4
Moderately
77
129
70
73
Poorly
28
53
25
27
Tumour size
6.67
0.010
0.92
0.337
≤5 cm
90
118
0.70
81
75
0.08
>5 cm
26
68
0.70
23
29
0.08
T stage
9.23
0.026
3.35
0.340
Tis-T1
24
19
0.36
22
19
0.07
T2
16
17
0.10
14
11
0.01
T3
47
89
0.08
43
37
0.10
T4
29
61
0.15
25
37
0.15
N stage
10.21
0.017
3.61
0.306
N0
58
64
0.28
55
42
0.03
N1
22
42
0.10
18
26
0.12
N2
23
37
0.08
18
20
0.02
N3
13
43
0.01
13
16
0.16
AJCC stage
11.24
0.004
1.06
0.588
I
36
31
0.29
33
27
0
II
38
56
0.09
35
35
0
III
42
99
0.05
36
42
0
Vascular invasion
7.86
0.005
0.74
0.390
No
111
159
0.20
99
96
0.09
Yes
5
27
0.12
5
8
0.11
SD: standard deviation; AJCC: American Joint Committee on Cancer; SIRI: systemic inflammation response index.